← All Cellebrite Di LTD filings

Cellebrite Di LTD 20-F annual reports

The annual report filed by foreign private issuers listed on a US exchange — the 10-K’s equivalent for non-US companies.

NASDAQ
CLBT
Cellebrite Di LTD
20-F: Cellebrite DI Ltd. Reports Fiscal Year 2024 Results in Form 20-F Filing
Cellebrite DI Ltd. files its Form 20-F, reporting a revenue increase to $401 million for fiscal year 2024, alongside a net loss of $283 million.
NASDAQ
CLBT
Cellebrite Di LTD
20-F/A: Cellebrite Amends 20-F Filing to Correct Share Price Trigger for Price Adjustment Shares
Cellebrite files an amendment to its 20-F annual report to correct a typographical error related to the share price triggering event for the issuance of Price Adjustment Shares.
NASDAQ
CLBT
Cellebrite Di LTD
20-F: Cellebrite DI Ltd. Files 20-F Annual Report, Certifies Financial Accuracy
Cellebrite DI Ltd. has filed its annual report on Form 20-F, with the CEO and CFO certifying the accuracy and compliance of the financial information.